Maintenance olaparib in Asian patients with germline BRCA-mutated metastatic pancreatic cancer

被引：0

作者：

Oh, Do-Youn ^{[1
]}

Park, Joon Oh ^{[2
]}

Kindler, Hedy L. ^{[3
]}

Hammel, Pascal ^{[4
]}

Reni, Michele ^{[5
]}

Van Cutsem, Eric ^{[6
]}

Macarulla, Teresa ^{[7
]}

Hall, Michael J. ^{[8
]}

Arnold, Dirk ^{[9
]}

Reinacker-Schick, Anke ^{[10
]}

Tortora, Giampaolo ^{[11
]}

Algul, Hana ^{[12
]}

O'Reilly, Eileen M. ^{[13
]}

McGuiness, David ^{[14
]}

Liu, Yu-Zhen ^{[14
]}

Cui, Karen ^{[15
]}

Schlienger, Katia ^{[16
]}

Locker, Gershon Y. ^{[15
]}

Golan, Talia ^{[17
]}

机构：

[1] Seoul Natl Univ, Coll Med, Canc Res Inst, Seoul Natl Univ Hosp, Seoul, South Korea

[2] Sungkyunkwan Univ, Samsung Med Ctr, Sch Med, Seoul, South Korea

[3] Univ Chicago, Chicago, IL 60637 USA

[4] Univ Paris VII, Hop Beaujon Clichy, Paris, France

[5] IRCCS Osped San Raffaele Sci Inst, Milan, Italy

[6] Katholieke Univ Leuven, Univ Hosp Gasthuisberg, Leuven, Belgium

[7] Vall Hebron Univ Hosp, Inst Oncol, Barcelona, Spain

[8] Fox Chase Canc Ctr, Philadelphia, PA USA

[9] Asklepios Tumorzentrum Hamburg Asklepios Klin Al, Hamburg, Germany

[10] Ruhr Univ Bochum, St Josef Hosp, Bochum, Germany

[11] Fdn Policlin Gemelli IRCCS, Med Oncol Unit, Rome, Italy

[12] Tech Univ Munich, Klin Rechts Isar, Munich, Germany

[13] Memorial Sloan Kettering Canc Ctr, New York, NY USA

[14] AstraZeneca, Cambridge, England

[15] AstraZeneca, Gaithersburg, MD USA

[16] Merck & Co Inc, Kenilworth, NJ USA

[17] Tel Aviv Univ, Sheba Med Ctr, Inst Oncol, Tel Aviv, Israel

来源：

ANNALS OF ONCOLOGY | 2021年 / 32卷

关键词：

D O I：

10.1016/j.annonc.2021.05.643

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

MO31-6

引用

页码：S319 / S319

页数：1

共 50 条

[1] Maintenance Olaparib for Germline BRCA-Mutated Metastatic Pancreatic Cancer
Golan, Talia
Hammel, Pascal
Reni, Michele
Van Cutsem, Eric
Macarulla, Teresa
Hall, Michael J.
Park, Joon-Oh
Hochhauser, Daniel
Arnold, Dirk
Oh, Do-Youn
Reinacher-Schick, Anke
Tortora, Giampaolo
Alguel, Hana
O'Reilly, Eileen M.
McGuinness, David
Cui, Karen Y.
Schlienger, Katia
Locker, Gershon Y.
Kindler, Hedy L.
NEW ENGLAND JOURNAL OF MEDICINE, 2019, 381 (04): : 317 - 327
[2] Cost-Effectiveness of Maintenance Olaparib for Germline BRCA-Mutated Metastatic Pancreatic Cancer
Wu, Bin
Shi, Lizheng
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2020, 18 (11): : 1528 - +
[3] Olaparib for Metastatic Germline BRCA-Mutated Breast Cancer
Narod, Steven
Booth, Christopher M.
Foulkes, William D.
NEW ENGLAND JOURNAL OF MEDICINE, 2017, 377 (18): : 1792 - 1792
[4] Cost-Effectiveness Analysis of Olaparib Maintenance Treatment for Germline BRCA-Mutated Metastatic Pancreatic Cancer
Li, Na
Zheng, Huanrui
Huang, Yanlei
Zheng, Bin
Cai, Hongfu
Liu, Maobai
FRONTIERS IN PHARMACOLOGY, 2021, 12
[5] Patient-centered outcomes in the POLO study of active maintenance olaparib for germline BRCA-mutated metastatic pancreatic cancer
Kindler, Hedy L.
Yoo, Hyun Kyoo
Hettle, Robert
Cui, Karen Y. Y.
Joo, Seongjung
Locker, Gershon Y.
Golan, Talia
CANCER, 2023, 129 (09) : 1411 - 1418
[6] Overall survival from the phase 3 POLO trial: Maintenance olaparib for germline BRCA-mutated metastatic pancreatic cancer.
Golan, Talia
Hammel, Pascal
Reni, Michele
Van Cutsem, Eric
Macarulla, Teresa
Hall, Michael J.
Park, Joon Oh
Hochhauser, Daniel
Arnold, Dirk
Oh, Do-Youn
Reinacher-Schick, Anke C.
Tortora, Giampaolo
Algul, Hana
O'Reilly, Eileen Mary
McGuinness, David
Cui Karen
Schlienger, Katia
Locker, Gershon Y.
Kindler, Hedy L.
JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (03)
[7] Overview: FDA Approval of Olaparib Maintenance for BRCA-Mutated Ovarian Cancer
Saleh, Naveed
Copur, Mehmet Sitki
ONCOLOGY-NEW YORK, 2019, 33 (07): : 293 - 294
[8] Overall Survival Results From the POLO Trial: A Phase III Study of Active Maintenance Olaparib Versus Placebo for Germline BRCA-Mutated Metastatic Pancreatic Cancer
Kindler, Hedy L.
Hammel, Pascal
Reni, Michele
Van Cutsem, Eric
Macarulla, Teresa
Hall, Michael J.
Park, Joon Oh
Hochhauser, Daniel
Arnold, Dirk
Oh, Do-Youn
Reinacher-Schick, Anke
Tortora, Giampaolo
Alguel, Hana
O'Reilly, Eileen M.
Bordia, Sonal
McGuinness, David
Cui, Karen
Locker, Gershon Y.
Golan, Talia
JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (34) : 3929 - +
[9] Olaparib for BRCA-mutated advanced ovarian cancer
de Lartigue, Jane
JOURNAL OF COMMUNITY AND SUPPORTIVE ONCOLOGY, 2015, 13 (06): : 206 - 208
[10] Adjuvant Olaparib in BRCA-Mutated Breast Cancer
Hoshi, Aoi
Bando, Hiroko
Sekine, Ikuo
NEW ENGLAND JOURNAL OF MEDICINE, 2021, 385 (15): : 1439 - 1440

← 1 2 3 4 5 →